Fusion Mandarin Orange Tattoo Ink 1 oz.

Marsoni

M251S

$16.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Fusion Mandarin Orange Tattoo Ink 1 oz.There's nothing foreign about 1 oz. Fusion Mandarin Orange Tattoo Ink. If this awesome orange brings a sense of familiarity, that's because it's one of the most vibrant shades of the color made. It goes on easily and is every bit as bright on the skin as it is in the bottle. Fusion Ink is a family owned business run by tattoo artists. Who better to know the value of top notch inks with high pigment loads? These in demand inks rely on natural

Easy Shipping

Quick Dispatch:

Your Fusion Mandarin Orange Tattoo Ink 1 oz. orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Fusion Mandarin Orange Tattoo Ink 1 oz. ships.

Need Help?
Questions about Fusion Mandarin Orange Tattoo Ink 1 oz., sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Fusion Mandarin Orange Tattoo Ink 1 oz. in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

I know it’s expensive but for us we love it. Clean ingredients. It’s worth it! I’ve used Tubby Todd on all my babies and it’s been a lifesaver! I buy it every month and now use it on my third baby—it’s gentle, effective, and works wonders for sensitive skin. The All Over Ointment especially helps so much with eczema and dry patches, keeping skin soft and calm. Such a reliable brand I keep coming back to again and again. Definitely a must-have for parents!

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on September 11, 2025